IBM, Teva Pharmaceutical partner for new drug discovery & enhanced chronic disease management

IBM and Teva Pharmaceutical are expanding their existing global e-Health alliance to focus on discovering new treatment options and improving chronic disease management.

The expanded collaboration will include a three-year research partnership to develop a systematic process for drug repurposing and studying new uses for existing drugs. The collaboration will also feature chronic disease management initiative, which will combine Teva's therapeutic technologies with IBM Watson's cognitive computing. Respiratory and central nervous system diseases will be their chronic disease management initiative's first targets.

The initiative will integrate data from The Weather Company, an IBM Business, into the analysis that will run on the IBM Watson Health Cloud.

"IBM and Teva's announcements today are notable for two reasons. First, IBMs work with Teva extends from the biopharmaceutical research bench to an individual's medicine cabinet — underscoring the power of Watson cognitive computing across life sciences and healthcare. Second, this work includes the first integration of data from The Weather Company with the Watson Health Cloud, a milestone and demonstrable of how the definition of health data is evolving," said Deborah DiSanzo, general manager for IBM Watson Health, in a statement.

More articles on health IT:
Uber delivers free flu shots in 15 cities
Google donates $5M to Australian 'best in the world' healthcare startups
American Red Cross, Teladoc partner for disaster relief telehealth platform

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months